According to new research, positive discordance as measured by a glycation ratio of glucose management indicator and haemoglobin A1c (GMI/A1c) was associated with a risk

On June 26 2023, the American Diabetes Association® (ADA) presented Carmella Evans-Molina, MD, PhD, Eli Lilly Professor of Paediatric Diabetes, Indiana University (IU) School of

In the symposium Engineering and Site Consideration for Cell Therapy on Monday, June 25, panellists discussed cell therapy and the mission to develop new methods

Approximately fifty percent of patients with endstage renal disease in developed countries have diabetes, according to the National Institutes of Health (NIH), and the prevention

There is accumulating evidence regarding the cardiovascular benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists in patients with type

This paper was presented by Drs Jean Lu, Cheng Yi Yuan, Yee W. Kong, Emma Netzer, Huanping Wu, Thomas Seidl, David N. O’neal from Melbourne,

This paper was presented by Drs Carel Le Roux, Oren Steen, Kathryn J. Lucas, Elena Startseva, Anna Unseld, Anita M. Hennige from Dublin, Ireland, Toronto,

When a patient’s therapeutic objectives are not met, therapeutic inertia is the failure to initiate, intensify, or sometimes de-intensify therapy. It is a frequent issue

In November 2022, the U.S. Food and Drug Administration approved teplizumab, a CD3- directed monoclonal antibody and the first drug to be approved for the

In a new feature at the 83 Scientific Sessions, six diabetes innovators will have the opportunity to present their ideas to a panel of potential